Terapia oparta na peryndoprylu w prewencji sercowo-naczyniowej: łączona analiza badań ADVANCE, EUROPA i PROGRESS

Jasper J. Brugts i wsp – The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials European Heart Journal Advance Access published online on April 4, 2009

Conclusion: This study provides strong evidence for a consistent cardiovascular protection with an ACE-inhibitor treatment regimen (perindopril–indapamide) by improving survival and reducing the risk of major cardiovascular events across a broad spectrum of patients with vascular disease.

Opracowane na podstawie: European Heart Journal Advance Access published online on April 4, 2009 / 2009-04-08